Dilshad H. Khan
- Molecular Biology top 10%
- Histone Deacetylase Inhibitors Research 10
- Protein Degradation and Inhibitors 9
- Epigenetics and DNA Methylation 5
- RNA Research and Splicing 4
- RNA modifications and cancer 4
- Ubiquitin and proteasome pathways 4
- Genomics and Chromatin Dynamics 3
- Hematology top 10%
- Acute Myeloid Leukemia Research 7
Dilshad H. Khan
21 papers receiving 875 citations
Peers
Comparison fields: 5 of 85
- Molecular Biology 732
- Cancer Research 108
- Hematology 78
- Oncology 163
- Geriatrics and Gerontology 18
Countries citing papers authored by Dilshad H. Khan
This map shows the geographic impact of Dilshad H. Khan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dilshad H. Khan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dilshad H. Khan more than expected).
Fields of papers citing papers by Dilshad H. Khan
This network shows the impact of papers produced by Dilshad H. Khan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dilshad H. Khan. The network helps show where Dilshad H. Khan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Dilshad H. Khan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 10 | |
| 2 | 2023 | 0 | |
| 3 | 2021 | 103 | |
| 4 | 2021 | 32 | |
| 5 | 2020 | 1 | |
| 6 | 2018 | 64 | |
| 7 | 2018 | 4 | |
| 8 | 2017 | 1 | |
| 9 | 2017 | 14 | |
| 10 | 2016 | 16 | |
| 11 | 2014 | 2 | |
| 12 | 2013 | 17 | |
| 13 | 2013 | 46 | |
| 14 | 2013 | 9 | |
| 15 | 2013 | 44 | |
| 16 | 2012 | 53 | |
| 17 | 2012 | 36 | |
| 18 | 2012 | 404 | |
| 19 | Gene expression regulation through 14-3-3 interactions with histones and HDACs. | 2011 | 20 |
| 20 | 2009 | 9 |
About Dilshad H. Khan
Dilshad H. Khan is a scholar working on Hematology, Molecular Biology and Rheumatology, having authored 22 papers that have together received 887 indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (10 papers), Protein Degradation and Inhibitors (9 papers), Acute Myeloid Leukemia Research (7 papers), Epigenetics and DNA Methylation (5 papers), RNA Research and Splicing (4 papers), RNA modifications and cancer (4 papers), Ubiquitin and proteasome pathways (4 papers) and Genomics and Chromatin Dynamics (3 papers). The work is most often cited by research in Molecular Biology (732 citations), Cancer Research (108 citations) and Hematology (78 citations). Dilshad H. Khan has collaborated with scholars based in Canada, United States and Israel. Frequent co-authors include James Davie, Geneviève P. Delcuve, Aaron D. Schimmer, Shannon Healy, Shihua He, Jong Bok Lee, Sara Mirali, Christian Seiser, Stefan Winter and Jenny Yu. Their work appears in journals such as Nucleic Acids Research, Journal of Biological Chemistry and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.